2644
C. Schuster et al. / Tetrahedron: Asymmetry 16 (2005) 2631–2647
J = 6.6 Hz), 1.92–0.67 [m, 26H, 17MBE-aliphatic,
therein 0.77:0.75:0.67 (3s 9H, 3MBE-CH3), 0.73 (s,
9H, O–C(CH3)3)]. 13C NMR (50 MHz, CDCl3): dC =
144.9:140.8 (2s, Ph–C-1), 128.6:127.8:127.3:127.2:
127.1:126.6 (6d, Ph–C), 100.7 (d, C-2), 89.6 (d, C-7a),
79.0:77.6 (2d, Ph–CH–O), 74.1 (s, O–C(CH3)3), 48.1
(d, C-4), 46.8 (s, C-7), 46.8 (s, C-8), 45.9 (d, C-3a),
38.3 (t, C-3), 32.1 (t, C-6), 29.0 (t, C-5), 28.1 (q, O–
C(CH3)3), 22.8:20.5:11.4 (3q, 3MBE-CH3). Anal. Calcd
for C30H40O3 · 0.1 H2O: C, 79.99; H, 9.00. Found: C,
80.02; H, 9.19.
(t, O–CH2–Ph). Anal. Calcd for C21H20O2: C, 82.86;
H, 6.62. Found: C, 82.86; H, 6.89.
4.5.1.2. (1R,2S)-2-(2-Methylpropoxy)-1,2-diphenyleth-
anol, 5c. 0.22 g (yield 77% over two steps from 3a)
white solid, mp 57–60 ꢂC, Rf = 0.51 (PE/E 3:1),
20
½aꢂD ¼ þ43.7 (c 0.90, CH2Cl2). 1H NMR (200 MHz,
CDCl3, TMS): dH = 7.33–7.14 (m, 10H, aromatic),
4.86 (dd, 1H, Ph–CH–O, J1 = 5.6 Hz, J2 = 4.1 Hz),
4.41 (d, 1H, Ph–CH–O, J = 5.6 Hz), 3.17:3.02 (2dd,
2H, O–CH2–CH(CH3)2, J1AB = 9.0 Hz, J2 = 6.7 Hz),
2.54 (d, 1H, OH, J = 4.1 Hz), 1.84 (m, 1H, O–CH2–
CH(CH3)2), 0.85:0.84 (2d, 6H, O–CH2–CH(CH3)2,
J = 6.7 Hz). 13C NMR (50 MHz, CDCl3): dC =
140.4:138.1 (2s, Ph–C-1), 127.9:127.8:127.7:127.6:
127.3:127.1 (6d, Ph–C), 86.0:77.1 (2d, Ph–CH–O), 76.0
(t, O–CH2–CH(CH3)2), 28.5 (d, O–CH2-CH(CH3)2),
19.3:19.2 (2q, O–CH2–CH(CH3)2). Anal. Calcd for
C18H22O2: C, 79.96; H, 8.20. Found: C, 79.37; H, 8.48.
4.4.11.2. [2S-(2a(1S*,2R*),3aa,4b,7b,7aa)]-2-[2-(1,1-
Dimethyl-2-phenylethoxy)-1,2-diphenyl-ethoxy]octahydro-
7,8,8-trimethyl-4,7-methanobenzofuran,
12c. 0.240 g
(yield 90%) colourless oil, Rf = 0.69 (PE/E 10:1),
20
½aꢂD ¼ ꢀ65.8 (c 1.00, CH2Cl2). 1H NMR (200 MHz,
CDCl3, TMS): dH = 7.44–7.12 (m, 15H, aromatic),
4.85 (d, 1H, 2-H, J = 3.7 Hz), 4.52:4.38 (2d, 2H, Ph–
CH–O, J = 8.3 Hz), 2.56:2.47 (2d, 2H, O–C(CH3)2–
CH2–Ph, JAB = 18.6 Hz), 2.24 (d, 1H, 7a-H,
J = 6.6 Hz), 1.97–0.87 (m, 14H, MBE-aliphatic), 0.82
(s, 6H, O–C(CH3)2–CH2–Ph), 0.73 (s, 6H, 2MBE-
CH3), 0.56 (s, 3H, 1MBE-CH3). 13C NMR (50 MHz,
CDCl3): dC = 144.8:140.6:138.4 (3s, Ph–C-1), 130.9–
125.8 (m, Ph–C), 100.9 (d, C-2), 89.7 (d, C-7a),
79.2:77.5 (2d, Ph–CH–O), 76.5 (s, O–C(CH3)2–CH2–
Ph), 49.2 (t, O–C(CH3)2–CH2–Ph), 48.1 (d, C-4), 46.9
(s, C-8), 45.9 (d, C-3a), 38.3 (t, C-3), 32.1 (t, C-6), 28.9
(t, C-5), 25.9:24.2 (2q, O–C(CH3)2–CH2–Ph),
22.8:20.5:11.5 (3q, 3MBE-CH3). Anal. Calcd for
C36H44O3 · 0.1 H2O: C, 82.12; H, 8.46. Found: C,
82.26; H, 8.60.
4.5.1.3. (1R,2S)-2-(2-Methoxy-1,1-dimethylethoxy)-
1,2-diphenylethanol, 5d. 0.171 g (yield 91%) colourless
20
oil, Rf = 0.18 (PE/E 4:1), ½aꢂD ¼ þ123.2 (c 0.56, CH2Cl2).
1H NMR (200 MHz, CDCl3, TMS): dH = 7.19–7.04 (m,
10H, aromatic), 4.86:4.68 (2d, 2H, Ph–CH–O, J =
4.6 Hz), 3.82 (s, 1H, OH), 3.34 (s, 3H, O–CH3),
3.42:3.09 (2d, 2H, CH2–O–CH3, J = 9.8 Hz), 1.15:0.94
(2s, 6H, O–C(CH3)2–CH2–OH). 13C NMR (50 MHz,
CDCl3): dC = 141.1:140.1 (2s, Ph–C-1), 127.5–126.9
(m, Ph–C), 78.0 (t, CH2–O), 78.0 (s, O–C(CH3)2),
77.9:75.8 (2d, Ph–CH–O), 58.9 (q, O–CH3), 25.0:23.0
(2q, O–C(CH3)2). Anal. Calcd for C19H24O3 · 0.2 H2O:
C, 75.07; H, 8.09. Found: C, 75.06; H, 8.13.
4.5. Deprotection of auxiliary precursors 4a,c, 12a–c
4.5.1.4. (1R,2S)-2-(1,1-Dimethylethoxy)-1,2-diphenyl-
ethanol, 5e. 0.152 g (yield 84%) white solid, mp 73–
4.5.1. General procedure. Ethers 4a,c, 12a–c (1 equiv)
and a catalytic amount of p-TsOH were dissolved in a
10-fold amount of a mixture of methanol/dichlorometh-
ane (1:1) and stirred overnight at room temperature.
After TLC analysis had shown total conversion, a satu-
rated aqueous NaHCO3 solution was added and stirring
continued for 10 min. The organic solvents were evapo-
rated and the aqueous remains diluted with water and
extracted three times with ether. The combined ether
extracts were washed with brine, dried over Na2SO4, fil-
tered and evaporated. The crude product was purified
by vacuum flash chromatography on silica gel, eluting
with petroleum ether/ether (20:1 ! 1:1). Methyl acetal
was recovered as an additional product fraction for
recyclation of Noeꢀs chiral protecting group.3
20
75 ꢂC, Rf = 0.43 (PE/E 3:1), ½aꢂD ¼ þ55.8 (c 0.64,
CH2Cl2). 1H NMR (200 MHz, CDCl3, TMS):
dH = 7.32–7.10 (m, 10H, aromatic), 4.70 (dd, 1H, Ph–
CH–O, J1 = 6.0 Hz, J2 = 3.7 Hz), 4.54 (d, 1H, Ph–
CH–O, J = 6.0 Hz), 2.36 (d, 1H, OH, J = 3.7 Hz), 0.99
(s, 9H, O–C(CH3)3). 13C NMR (50 MHz, CDCl3):
dC = 141.5:140.9 (2s, Ph–C-1), 127.7:127.5:127.5:127.3:
127.3:127.2 (6d, Ph–C), 78.3:78.0 (2d, Ph–CH–O), 74.9
(s, O–C(CH3)3), 28.4 (q, O–C(CH3)3). Anal. Calcd for
C18H22O2 · 0.1 H2O: C, 79.43; H, 8.22. Found: C,
79.67; H, 8.23.
4.5.1.5. (1R,2S)-2-(1,1-Dimethyl-2-phenylethoxy)-1,2-
diphenylethanol, 5f. 0.125 g (yield 82%) colourless oil,
20
1
Rf = 0.39 (PE/E 3:1), ½aꢂD ¼ þ1.4 (c 1.00, CH2Cl2). H
NMR (200 MHz, CDCl3, TMS): dH = 7.37–7.13
(m, 15H, aromatic), 4.71 (dd, 1H, Ph–CH–O, J1 =
5.8 Hz, J2 = 3.4 Hz), 4.63 (d, 1H, Ph–CH–O, J =
5.8 Hz), 2.77:2.69 (2d, 2H, O–C(CH3)2–CH2–Ph,
J = 13.2 Hz), 2.39 (d, 1H, OH, J = 3.4 Hz), 0.96:0.89
(2s, 6H, O–C(CH3)2–CH2–Ph). 13C NMR (50 MHz,
CDCl3): dC = 141.3:140.6:138.1 (3s, Ph–C-1), 130.8–
126.1 (m, Ph–C), 78.2:77.9 (2d, Ph–CH–O), 77.1 (s,
O–C(CH3)2–CH2–Ph), 49.2 (t, O–C(CH3)2–CH2–Ph),
26.1:24.7 (2q, O–C(CH3)2–CH2–Ph). Anal. Calcd for
4.5.1.1.
(1R,2S)-2-Benzyloxy-1,2-diphenylethanol,
5a. 3.43 g (yield 88% over two steps from 3a) white
20
solid, mp 77–79 ꢂC, Rf = 0.30 (PE/E 3:1), ½aꢂD ¼ þ31.1
1
(c 1.00, CH2Cl2). H NMR (200 MHz, CDCl3, TMS):
dH = 7.38–7.07 (m, 15H, aromatic), 4.91 (dd, 1H, Ph–
CH–O, J1 = 4.0 Hz, J2 = 4.0 Hz), 4.51:4.24 (2d, 2H,
O–CH2–Ph, J = 12.0 Hz), 4.49 (d, 1H, Ph–CH–O,
J = 4.0 Hz), 2.32 (d, 1H, OH, J = 4.0 Hz). 13C NMR
(50 MHz, CDCl3): dC = 140.4:137.9:137.6 (3s, Ph–C-1),
128.3–127.1 (m, Ph–C), 85.0:77.0 (2d, Ph–CH–O), 70.6